Firefly Luciferase siRNA LNP Premade Lipid Nanoparticle Kit
Firefly Luciferase siRNA-LNP is a lipid nanoparticle (LNP) containingFirefly Positive Control siRNA. LNP can facilitate transfection of encapsulated siRNA into cells or in vivo delivery.
This product utilizes the lipid nanoparticle technology for simple and efficient delivery of siRNA to a variety of mammalian cells, including cell cultures which may typically be prone to difficulties in expressing desired proteins. The LNP’s used are formulated with ionizable lipid, DSPC, cholesterol, and DMG-PEG2000 at optimal molar concentration for a high rate of encapsulation and efficient mRNA delivery.
Firefly luciferase, originally extracted from firefly Photinus pyralis, can catalyze the oxidation of substrate D-luciferin to emit light at a wavelength of about 560nm. Firefly luciferase is a commonly used reporter gene, which is often used in the study of gene regulation and function.
This product is suitable for research of siRNA delivery, translation efficiency, cell viability, etc.
Payload: | Firefly LuciferasePositive Control siRNA |
---|---|
Formulation: | Ionizable lipid, DSPC, PEG-2000 DMG, Cholesetrol |
Storage Buffer: | 10% Sucrose in PBS |
Appearance: | Clear and colorless |
Storage: | -20° C or below. We recommend to minimize freeze-thaw cycles to preserve LNPs integrity. |
Shipping: | Dry ice |
Handling: | Avoid freeze and thaw |
Concentration: | ~0.1 mg/mL |
Stock: | On-demand |
Special formulation and other requirements are available up request. Contact us.
For Research Use Only. Not for use in diagnostic procedures.
Luciferase siRNA LNP Premade Lipid Nanoparticle Kit
More Information